Emergent BioSolutions to repay $353 million under revolver

By Taylor Fox

New York, Aug. 4 – Emergent BioSolutions Inc. plans to use net proceeds from its offering of $400 million senior notes to repay the $353 million outstanding under its $600 million revolving credit facility, according to a news release.

Remaining proceeds will be used for general corporate purposes.

Emergent BioSolutions is a Gaithersburg, Md.-based life sciences company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.